3 Easy Steps

  • 1Search for courses by Study Area, Level and Location
  • 2We deliver you all the matched results
  • 3Choose one or more course providers to contact you

Distance from location (kms)

Exact 5 10 25 50 100

Posted since

All 2 Days 1 Week 2 Weeks 1 Month

Sort results by

Relevance Date



Research Scientist, Antibody Discovery And Protein Engineering

Private Company - Australia Plains, SA

Source: uWorkin


About CSL

With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.

CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL's therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!

Job Description

The Opportunity

We have an exciting opportunity for a Research Scientist to join the Antibody Discovery & Protein Engineering group. Basedin our Research Department at the Bio21 Institute in Parkville, you will apply high-quality molecular biology skills, focusing on the isolation and engineering of human therapeutic antibodies and serum proteins using principally phage and mammalian display technologies. Under the guidance of senior members of the group you will become a key player in the optimisation of therapeutic antibody and serum protein drug candidates designed to treat human diseases with high, unmet medical needs.

The Role

It is the successful candidate's responsibility to:

  • Perform phage display and mammalian display experiments to isolate and engineer therapeutic lead candidates.
  • Provide relevant scientific and technical knowledge of molecular cloning and biochemical characterisation of recombinant antibodies.
  • Explore and establish new research techniques and processes in collaboration with senior colleagues.
  • Participate at research group meetings and present work as required.
  • Work collaboratively across multiple internal groups, participating on project teams to deliver on common goals.
  • Share expertise and develop strong working relationships with team members.
  • Ensure the effective management of all laboratory and project documentation.
  • Maintain awareness of the field of protein engineering.

To be successful

The applicant must possess the following qualifications and skills:

  • PhD or equivalent qualification, backed with relevant and demonstrated expertise in an academic or industry environment.
  • Ability to work independently, outstanding attention to detail, time management and organisational skills are complemented by your excellent communication skills.
  • Recent PhD graduates with relevant molecular biology skills and a strong interest in therapeutic protein engineering who are highly motivated are encouraged to apply.
  • Experience with protein display technologies and/or previous work with therapeutic antibodies will be highly regarded.

To Apply:

Applications must address the selection criteria above and include a current CV and covering letter.

Applications Close: 26th of February 2021

Employment screening, including criminal history, medical assessment, confirmation of experience and stated qualifications, Australian working rights and other relevant checks form part of the candidate suitability evaluation process.